Vistin Pharma
VISTN | OL
Overview
Corporate Details
- ISIN(s):
- NO0010734122
- LEI:
- 5967007LIEEXZXFQY092
- Country:
- Norway
- Address:
- Postboks 6735 Etterstad, 0609 Oslo
- Website:
- https://www.vistin.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vistin Pharma is a pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs). The company is a leading global producer and a dedicated European manufacturer of Metformin, the standard first-line treatment for Type 2 diabetes. Vistin Pharma focuses on high-quality, sustainable production, supplying Metformin Hydrochloride in both standard and Direct Compressible (DC) grades to leading international pharmaceutical companies. It serves a significant portion of the global demand for this essential medicine.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Vistin Pharma.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-15 08:00 |
Interim Report
Vistin Pharma ASA: Second quarter and YTD 2025 financial results - Attachment: …
|
English | 1.6 MB | |
| 2025-08-15 08:00 |
Investor Presentation
Vistin Pharma ASA: Second quarter and YTD 2025 financial results - Attachment: …
|
English | 1.9 MB | |
| 2025-08-15 08:00 |
Earnings Release
Vistin Pharma ASA: Second quarter and YTD 2025 financial results
|
English | 2.1 KB | |
| 2025-08-08 10:00 |
Regulatory News Service
Vistin Pharma ASA: Invitation to Q2 2025 conference call
|
English | 1.6 KB | |
| 2025-06-04 08:00 |
Notice of Dividend Amount
Ex dividend NOK 1.25 today
|
English | 330 bytes | |
| 2025-05-23 09:22 |
Report Publication Announcement
Financial calendar
|
English | 464 bytes | |
| 2025-05-23 09:22 |
Report Publication Announcement
Finansiell kalender
|
Norwegian | 448 bytes | |
| 2025-05-22 12:59 |
Post-Annual General Meeting Information
Vistin Pharma ASA: Minutes from the annual general meeting 2025
|
English | 897.7 KB | |
| 2025-05-22 12:59 |
Post-Annual General Meeting Information
Vistin Pharma ASA: Minutes from the annual general meeting 2025
|
English | 736 bytes | |
| 2025-05-22 09:56 |
Proxy Solicitation & Information Statement
Disclosure of voting rights at AGM in Vistin Pharma ASA
|
English | 963 bytes | |
| 2025-05-07 13:30 |
Board/Management Information
Vistin Pharma ASA (VISTN): Update from the Election Committee
|
English | 1.3 KB | |
| 2025-05-06 13:03 |
Director's Dealing
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 168.6 KB | |
| 2025-05-06 13:03 |
Director's Dealing
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 172.1 KB | |
| 2025-05-06 13:03 |
Director's Dealing
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 217.6 KB | |
| 2025-05-06 13:03 |
Major Shareholding Notification
Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of la…
|
English | 1.6 KB |
Automate Your Workflow. Get a real-time feed of all Vistin Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Vistin Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
